RI
RTW Investments Portfolio holdings
AUM
$7.02B
This Quarter Return
+65.81%
1 Year Return
+28.16%
3 Year Return
+245.48%
5 Year Return
+425.65%
10 Year Return
+5,642.23%
AUM
$2.65B
AUM Growth
+$2.65B
(+58%)
Cap. Flow
+$209M
Cap. Flow
% of AUM
7.89%
Top 10 Holdings %
Top 10 Hldgs %
54.64%
Holding
73
New
13
Increased
31
Reduced
10
Closed
12
Top Buys
| 1 |
Immunovant
IMVT
|
$66M |
| 2 |
Q32 Bio
QTTB
|
$39.3M |
| 3 |
Relmada Therapeutics
RLMD
|
$25.9M |
| 4 |
AVDL
Avadel Pharmaceuticals
AVDL
|
$25.7M |
| 5 |
Korro Bio
KRRO
|
$21.8M |
Top Sells
| 1 |
ACHN
Achillion Pharmaceuticals, Inc.
ACHN
|
$39.5M |
| 2 |
Sarepta Therapeutics
SRPT
|
$15.3M |
| 3 |
Alnylam Pharmaceuticals
ALNY
|
$14.9M |
| 4 |
QuidelOrtho
QDEL
|
$10.8M |
| 5 |
QTNT
Quotient Limited Ordinary Shares
QTNT
|
$9.95M |
Sector Composition
| 1 | Healthcare | 94.97% |
| 2 | Communication Services | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Arvinas
ARVN
$580M
| $27.5M | 1.04% |
670,295
-139,328
| -17% | -$5.72M |
|
|
TBIO
27
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $26.9M | 1.02% |
3,304,808
+156,180
| +5% | +$1.27M |
|
|
28
Relmada Therapeutics
RLMD
$48.8M
| $25.9M | 0.98% |
+664,484
| New | +$25.9M |
|
|
AVDL
29
Avadel Pharmaceuticals
AVDL
$1.45B
| $25.7M | 0.97% |
+3,401,434
| New | +$25.7M |
|
|
30
Korro Bio
KRRO
$244M
| $21.8M | 0.82% |
+26,057
| New | +$21.8M |
|
31
Castle Biosciences
CSTL
$673M
| $21.7M | 0.82% |
631,072
-113,973
| -15% | -$3.92M |
|
32
MiMedx Group
MDXG
$1.05B
| $20.5M | 0.77% |
2,702,539
-261,461
| -9% | -$1.98M |
|
33
Exagen
XGN
$213M
| $18.3M | 0.69% |
718,946
+207,313
| +41% | +$5.27M |
|
34
Protagonist Therapeutics
PTGX
$3.62B
| $17.3M | 0.65% |
2,459,988
+1,697,705
| +223% | +$12M |
|
35
Johnson & Johnson
JNJ
$429B
| $17M | 0.64% |
116,858
| – | – |
|
|
NSTG
36
DELISTED
NanoString Technologies, Inc.
NSTG
| $16.1M | 0.61% |
+578,932
| New | +$16.1M |
|
37
Arbutus Biopharma
ABUS
$753M
| $15.8M | 0.59% |
5,666,754
+103,787
| +2% | +$289K |
|
38
TELA Bio
TELA
$65.4M
| $14.8M | 0.56% |
+1,139,358
| New | +$14.8M |
|
39
Wave Life Sciences
WVE
$1.27B
| $13.7M | 0.52% |
+1,705,474
| New | +$13.7M |
|
40
Natera
NTRA
$23B
| $13.6M | 0.51% |
402,953
+115,483
| +40% | +$3.89M |
|
41
Agilent Technologies
A
$35.5B
| $12.8M | 0.48% |
+149,690
| New | +$12.8M |
|
42
Regenxbio
RGNX
$498M
| $12.5M | 0.47% |
305,611
+14,443
| +5% | +$592K |
|
43
Insulet
PODD
$24.2B
| $11.6M | 0.44% |
67,725
-43,507
| -39% | -$7.45M |
|
|
ODT
44
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| $11.6M | 0.44% |
356,752
+16,860
| +5% | +$547K |
|
45
uniQure
QURE
$954M
| $10.9M | 0.41% |
152,096
+7,187
| +5% | +$515K |
|
46
Clearside Biomedical
CLSD
$26.7M
| $10.9M | 0.41% |
3,750,107
+2,408
| +0.1% | +$6.98K |
|
47
STAAR Surgical
STAA
$1.35B
| $10.6M | 0.4% |
+302,211
| New | +$10.6M |
|
48
InMode
INMD
$917M
| $9.8M | 0.37% |
500,000
| – | – |
|
49
Transmedics
TMDX
$3.65B
| $9.57M | 0.36% |
503,266
| – | – |
|
|
BWAY
50
Brainsway
BWAY
$296M
| $9.35M | 0.35% |
958,426
+123,739
| +15% | +$1.21M |
|